What is Pacific Biosciences of California's total revenue?

Pacific Biosciences of California (PACB) reported total revenue of $37.18M in Q1 2026.

How has Pacific Biosciences of California's total revenue changed year-over-year?

Pacific Biosciences of California's total revenue increased by 0.1% year-over-year, from $37.15M to $37.18M.

What is the long-term trend for Pacific Biosciences of California's total revenue?

Over 4 years (2021 to 2025), Pacific Biosciences of California's total revenue has grown at a 5.2% compound annual growth rate (CAGR), from $130.51M to $160.01M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Pacific Biosciences of California PACB Total Revenue

Discontinued — last reported Q1 '26

Total Revenue at other companies

IlluminaILMN

$1.09B+4.8%

RevvityRVTY

$711.12M+7.0%

Maravai LifeSciences Holdings, Inc.MRVI

$65.84M+40.5%

Agilent TechnologiesA

$1.84B+10.0%

Thermo Fisher ScientificTMO

$11.01B+6.2%

Twist Bioscience CorporationTWST

$110.72M+19.3%

Segments

By product

See full

Consumable revenue$21.81M+8.5%

Instrument revenue$9.72M-11.8%

Service And Other$5.64M-6.6%

Service and other revenue$5.64M-6.6%

By geography

See full

Americas$16.69M+2.3%

Europe, Middle East and Africa$10.77M+16.5%

Asia-Pacific$9.72M-16.2%

By segment

See full

Reportable Segment$37.18M+0.1%

Other financials

Income statement

See full

Gross profit$12.8M+1,037%

Operating income-$8.4M+98.1%

Net income-$8.3M+98.1%

EPS (diluted)-$0.03+97.9%

Balance sheet

See full

Cash & equivalents$57.9M-4.7%

Total debt$59.3M+12.1%

Total equity$2.4M-97.4%

Total assets$782.4M-9.1%

Cash flow

See full

Operating cash flow-$44.7M-1.4%

CapEx$3.0M+119%

Free cash flow-$47.7M-5.0%

Valuation

See full

Market cap$496.96M+30.4%

Enterprise value$498.38M+33.5%

P/S3.1×+0.6×

Profitability

See full

Gross margin37.5%+21.3pp

Operating margin-83.3%-38.2pp

Net margin-80.3%-36.1pp

FCF margin-72.6%-20.0pp

Returns & leverage

See full

Return on equity-273.6%+314pp

Debt / equity25.1×+24.5×

Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pacific Biosciences of California's total revenue?: Pacific Biosciences of California (PACB) reported total revenue of $37.18M in Q1 2026.
How has Pacific Biosciences of California's total revenue changed year-over-year?: Pacific Biosciences of California's total revenue increased by 0.1% year-over-year, from $37.15M to $37.18M.
What is the long-term trend for Pacific Biosciences of California's total revenue?: Over 4 years (2021 to 2025), Pacific Biosciences of California's total revenue has grown at a 5.2% compound annual growth rate (CAGR), from $130.51M to $160.01M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.